CTRI/2022/07/043857已完成4 期
A post market clinical follow up prospective study to evaluate safety and performance of Eye Preparations - EYE WASH WITH HERBAL EXTRACT/Distilled Witch Hazel eye wash
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •At the time of screening and usage of the product all subjects must meet the following criteria for inclusion into the study and the subjects will receive the prescribed eye wash from the PI/CO-PI by a medical practitioner. The inclusion criteria for the subjects for this study are as follows:
- •-Subjects who experience irritation, soreness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment
排除标准
- •The below Subjects are excluded from the study:
- •-Subjects who are not willing to participate in the study
- •-Anyone with known allergic reaction to Eye wash with Herbal extract/Distilled witch Hazel Eye Wash
- •-Subjects with allergic reaction to any eye medication or any existing eye infection
- •-Subjects undergone recent (6 weeks) cataract surgery who are on other eye medications
研究者
相似试验
尚未招募
4 期
A study to evaluate safety and performance of Hydroxypropyl Methylcellulose Eye DropsCTRI/2024/06/069121Kilitch Healthcare India Ltd.
已完成
4 期
The purpose of the study is to evaluate safety and performance of Eye Preparations- Hypromellose plus Sodium Hyaluronate Eye Drops.CTRI/2022/07/043789STERICON PHARMA PRIVATE LIMITED54
尚未招募
4 期
A study to evaluate safety and performance of Sodium Hyaluronate Ophthalmic SolutioCTRI/2024/06/068514Kilitch Healthcare India Ltd.
已完成
4 期
The purpose of the study is to evaluate safety and performance of Eye Preparations - Sodium Chloride Eye Drop (0.75%) (Calendula extract plus Hamamelis extractCTRI/2022/07/043790STERICON PHARMA PRIVATE LIMITED72
已完成
4 期
Study is to evaluate safety and performance of Eye Preparations- Sodium Hyaluronate (0.1%, 0.2%, 0.3%, and 0.4%) Eye Drops.CTRI/2022/07/043786STERICON PHARMA PRIVATE LIMITED282
